Invention Application
- Patent Title: Her-2 neu dna vaccine having anti-cancer activity
- Patent Title (中): 具有抗癌活性的Her-2 neu dna疫苗
-
Application No.: US10521313Application Date: 2003-07-15
-
Publication No.: US20060074038A1Publication Date: 2006-04-06
- Inventor: Joon Lee , Dong-Hyeon Kim , Yeonseok Chung , Sun-Young Chang , Kyung-Chul Lee , Chang-Yuil Kang
- Applicant: Joon Lee , Dong-Hyeon Kim , Yeonseok Chung , Sun-Young Chang , Kyung-Chul Lee , Chang-Yuil Kang
- Applicant Address: KR Kwanak-gu, Seoul 151-742
- Assignee: PANGENOMICS CO., LTD
- Current Assignee: PANGENOMICS CO., LTD
- Current Assignee Address: KR Kwanak-gu, Seoul 151-742
- Priority: KR10-2002-0041764 20020716; KR10-2003-0038012 20030612
- International Application: PCT/KR03/01400 WO 20030715
- Main IPC: A61K48/00
- IPC: A61K48/00
Abstract:
The present invention relates to human Her-2/neu expressing plasmid constructs having anti-cancer activity and a DNA vaccine comprising same for preventing and/or treating cancer. The Her-2/neu DNA vaccines of the present invention can be effectively used as a therapeutic vaccine in reducing metastasis after tumor surgery or as a prophylactic vaccine for people with genetic high risk.
Information query
